Provides the 2020 ACC/AHA clinical performance and quality measures for the management of adults with heart failure.
Answers are grounded in this paper and cite their sources.
May support standardized risk assessment in HF performance measures; leaves open outcome impact in routine practice.
© 2020 by the American College of Cardiology Foundation and the American Heart Association, Inc. WRITING COMMITTEE MEMBERS Paul A. Heidenreich, MD, MS, FACC, FAHA, Chair Gregg C. Fonarow, MD, FACC, FAHA, FHFSA, Vice Chair* Khadijah Breathett, MD, MS, FACC, FAHA, FHFSA Corrine Y. Jurgens, PhD, RN, ANP, FAHA, FHFSA Barbara A. Pisani, DO, FACC, FAHA Bunny J. Pozehl, PhD, APRN-NP, FAHA, FHFSA John A. Spertus, MD, MPH, FACC, FAHA Kenneth G. Taylor, MD, FACC, FHFSA† Jennifer T. Thibodeau, MD, MSCS, FACC, FHFSA Clyde W. Yancy, MD, MSc, MACC, FAHA, FHFSA Boback Ziaeian, MD, PhD, FACC, FAHA Circulation: Cardiovascular Quality and Outcomes
No takes yet. Share an insight, caveat, or question.
Heidenreich et al. (2020) studied Heart Failure. 2020 ACC/AHA Clinical Performance and Quality Measures was evaluated. The 2020 ACC/AHA report defines clinical performance and quality measures for adults with heart failure; no quantitative trial data are reported in the abstract.
Synapse has enriched 10 related papers. Consider them for comparative context: